NCEs

Related by string. nce . nces . NCE . NCES * * o nce . O nce . nitric oxide donating NCEs . Civil Engineer NCE . chemical entities NCEs . entity NCE . NCE Diversified Flow Through . Education Statistics NCES . NCE Petrofund . Chemical Entity NCE . NCE Resources . Excellence NCE . NCES #-# *

Related by context. All words. (Click for frequent words.) 73 New Chemical Entities 66 chemical entities NCEs 63 Suven 61 molecular entities NMEs 60 ionotropic glutamate receptor antagonists 60 biologic therapeutics 60 Nanobodies ® 60 bio similars 60 entity NCE 59 Nanobody 59 Nanobody ® 59 NDDS 59 renin inhibitors 59 outlicensing 59 NMEs 59 Ganciclovir 59 prostone 59 therapeutic monoclonal antibodies 58 Anticalins 58 PDE4 inhibitor 58 Nanobodies 58 Ipca 58 HCV protease inhibitors 58 AMPK activators 58 cancer immunotherapies 58 Mipomersen 58 BCR ABL inhibitors 58 Perlecan 58 proteasome inhibitor 58 RhuDex ® 58 Shigamabs ® 58 elotuzumab 57 rxRNA 57 investigational compounds 57 aptamer therapeutics 57 anti infective 57 Aganocide 57 fusion enhancers 57 nitric oxide donating 57 oral proteasome inhibitor 57 biosimilar versions 57 Chemical Entity NCE 57 adrenergic regulation 57 prophylactic vaccines 57 anti CD# antibodies 57 dAbs 57 antisense drug 57 SERMs 57 selective androgen receptor modulators 57 Astex 57 TBC# 57 Indoco 56 Advinus 56 ALN PCS 56 NNR Therapeutics 56 histone deacetylase HDAC 56 vascular disrupting agents 56 polymerase inhibitors 56 NovaBay Aganocide compounds 56 EndoTAG TM 56 Interferon alpha 56 anticancer compounds 56 Civacir 56 Panzem 56 telomerase activators 56 BioSilicon 56 DOS# 56 Inotek Pharmaceuticals Corporation 56 NDDR 56 prescription dermatological 56 saquinavir 56 proteasome inhibitors 56 topical ophthalmic 56 topical dermatology 56 metaglidasen 56 outlicensed 56 SIRT1 activators 56 PEGylated 56 receptor modulators 56 Pancreate 56 CD# CEA 56 adipiplon 56 nucleoside analogues 55 Ecallantide 55 PDE4 inhibitors 55 VEGF inhibitors 55 NanoCrystal technology 55 siRNA therapeutics 55 TLR agonists 55 RNA therapeutics 55 GSK# [002] 55 VDAs 55 oral antiviral 55 humanized antibodies 55 antidiabetics 55 tubulin inhibitor 55 Angioblast 55 BioSilicon TM 55 nanoviricides 55 AKT inhibitor 55 isoform selective 55 tiapamil 55 TELINTRA 55 faropenem 55 ATL# [002] 55 antiviral compounds 55 Nascobal 55 therapeutic mAbs 55 Euroscreen 55 SARMs 55 MEK inhibitors 55 antisense drugs 55 NexACT ® 55 rxRNA compounds 55 Squalamine 55 Alkeran 55 Aviptadil 55 oral taxane 55 PITs 55 IAP inhibitors 55 RenaZorb TM 55 Mycograb 55 Clinigene 55 sirtuin modulators 55 Lupuzor 55 Adnectin 55 retapamulin 55 drug ISA# 55 Captisol ® 55 quinapril 55 Maxy G# 55 WILEX 55 AtuRNAi 55 nalbuphine ER 55 Dapagliflozin 55 HepDirect 55 NeuroSolutions 55 Pazopanib 55 Patent expiries 55 PROTONIX 55 Lubiprostone 55 recombinant antibodies 55 AEG# 55 LY# [003] 55 JAK inhibitor 55 SMARTICLES ® 55 HepeX B 54 RECOTHROM R 54 novel anti infective 54 PER.C6 r 54 GIPET 54 miconazole Lauriad ® 54 4SC AG 54 Urokinase 54 GSK '# 54 JAK inhibitors 54 Samjin 54 ddRNAi 54 ProNAi 54 Cx# [002] 54 biologicals 54 Perlecan Pharma 54 Biocon Biopharmaceuticals 54 Sutent sunitinib 54 Ophthotech 54 Aganocide ® 54 nitric oxide donating prostaglandin 54 ATL/TV# 54 Oncaspar 54 Sudhir Agrawal D.Phil 54 Onconase 54 Nanobody R 54 cytotoxics 54 Zemiva TM 54 Onalta 54 Vidofludimus 54 anti CD3 monoclonal 54 LNP formulations 54 carbapenem 54 TLR9 agonist 54 Piperacillin 54 Karo Bio 54 WinRho SDF 54 YONDELIS 54 Pantoprazole 54 NanoTab 54 Nektar pulmonary 54 incyclinide 54 Biochronomer 54 Captisol 54 recombinant factor VIIa 54 tranilast 54 TG# [003] 54 investigational monoclonal antibody 54 GPCR targets 54 NEUGENE 54 Proximagen 54 selective immunoproteasome inhibitor 54 Vegenics 54 kinase inhibitors 54 NTDDS 54 Alvesco R 54 TÎ ² 4 54 protein kinase inhibitors 54 Dr Reddys 54 liposomal delivery 54 Preclinical studies suggest 54 formulations 54 Factor VIIa 54 lixivaptan 54 nucleoside analogs 54 PORxin TM platforms 54 Glenmark Pharmaceuticals Ltd. 54 Heptares 54 Cerashield ™ 54 antithrombotics 54 CB1 antagonists 54 mAbs 54 ENMD # 54 Sanvar R 54 preclinically 54 RNAi therapeutic 54 EndoTAG 54 nanobodies 54 HepDirect R 54 ALK inhibitors 54 Novosom 54 Glenmark Pharmaceuticals 54 Dasatinib 54 CytoFabTM 54 antitumoral 54 Pertuzumab 54 Exelixis XL# 54 racemate 54 antisense compounds 54 Anidulafungin 54 PORxin TM 54 GPR# agonists 54 RNA antagonists 54 injectable formulations 54 cathepsin K inhibitor 54 Zydus Cadila 54 Metvix 54 Glenmark 54 NuMimetic TM 54 mertansine 54 Phylomer ® 54 Oglemilast 54 laninamivir 54 Ambrx 54 Strides Arcolab 53 ophthalmology oncology 53 TaiGen 53 HQK 53 novel peptides 53 anticoagulant reversing agent 53 research anddevelopment 53 novel anticancer 53 Galenea 53 etanercept Enbrel 53 HuCAL antibodies 53 biogeneric 53 CDP# 53 cancer therapeutics 53 NITD# 53 Curaxin 53 nicotinic alpha 7 53 CD# monoclonal antibody 53 resolvin 53 novel antiviral therapeutics 53 neurology dermatology 53 EHT AGN 53 Octreotide 53 vidofludimus 53 preclinical 53 Ciclesonide 53 iCeutica 53 zileuton 53 Cephalosporins 53 ChemBridge 53 GPR# agonist 53 GW# [003] 53 Emcure 53 Tasimelteon 53 JAK3 53 biobetter 53 multitargeted 53 ATG Fresenius S 53 Suven Life Sciences 53 looming patent expiries 53 Tekturna Rasilez 53 monoclonal antibody MAb 53 Santaris 53 THR beta agonist 53 antifungal agent 53 monoclonal antibody mAb 53 systemic RNAi 53 SOLVAY PHARMACEUTICALS 53 chemically modified siRNA 53 Maribavir 53 preclinical compounds 53 MAXY VII 53 miRNA therapeutics 53 biosimilar medicines 53 biopharmaceuticals 53 elbion 53 Vfend 53 Cellzome 53 TLR antagonists 53 Nautilus Biotech 53 humanized monoclonal antibodies 53 Cellcept 53 Biovitrum 53 DPX Survivac 53 Lovaza TM 53 sirtuin therapeutics 53 PrevOnco 53 VEGF receptor 53 Adenosine Therapeutics 53 immunomodulatory 53 A3 adenosine receptor 53 epigenetic therapies 53 pDNA vaccines 53 Intas 53 polyketides 53 Liprotamase 53 Japanese Encephalitis vaccine 53 therapeutic monoclonal antibody 53 L BLP# 53 glatiramer 53 Anticalins R 53 sublingual tablets 53 hydrophobic docetaxel prodrug nanoparticle 53 Topiramate tablets 53 pan HDAC inhibitor 53 therapeutic antibody 53 ganaxolone 53 casopitant 53 TLR9 agonists 53 oral PTH 53 siRNA therapeutic 53 therapeutics 53 Nexavar ® 53 PEG SN# 53 Gleevec imatinib mesylate 53 oncology therapeutics 53 INxin TM 53 Novartis Gleevec 53 chiral compounds 53 renin inhibitor 53 JAK2 inhibitor 53 Syncria 53 direct thrombin inhibitors 53 TKB# 53 GlycArt 53 Flutiform TM 53 Piramed 53 novel antibody therapeutics 53 beta interferons 53 Receptos 53 nucleoside 53 biosurgical 53 Captisol enabled 53 small molecule thrombopoietin 53 monoclonal 53 gets USFDA nod 53 Panzem R NCD 53 Zenapax 53 p# inhibitor 53 Multiferon R 53 SR Pharma 53 CCR9 antagonist 53 Litx 53 small molecule PEGylation 53 Viprovex TM 53 IV Busulfex 53 topical formulations 53 MediVas 53 Alnylam RNAi 53 Neulasta ® 53 SOLODYN R 53 Bharat Biotech 53 antibody therapeutics 53 Prodarsan ® 53 PDE# inhibitors 53 immune modulating 53 eligen R technology 53 RECALL VAX 53 Dicer Substrate Technology 53 allosteric modulator 53 HepaGam B 53 radezolid 53 Potelligent 53 antineoplastic 53 Rebif ® 53 MultiStat 53 macrolide antibiotics 53 MCSP respectively 53 CIMYM 53 Alvogen 53 Pfizer Sutent 53 TPI ASM8 53 Alnylam #x# 53 PhotoCure 53 SGLT Inhibitors 53 Urocidin 53 Photocure 53 mesylate 53 Accordion Pill 53 prodrugs 53 Fresenius Biotech 53 Spiegelmers ® 53 biosimilar 53 inlicensing 53 Firazyr 53 siRNAs targeting 53 PI3K inhibitors 53 selective GR 53 CyDex 53 peptide conjugated 53 Eligard R 53 RNA antagonist 53 Captisol Enabled 53 SinuNase ™ 53 SIRT1 activator 53 siRNA compounds 53 antithrombotic agents 52 azelastine 52 AERx iDMS 52 antimitotic 52 Loramyc R 52 XmAb ® 52 TRAIL receptor antibodies 52 Arch Pharmalabs 52 Ethyol 52 HIV integrase inhibitor 52 Archexin 52 Oral Insulin 52 Akzo Nobel Organon 52 Trofex TM 52 epigenetic therapeutics 52 voclosporin 52 Unit Dose Budesonide 52 small molecule activators 52 Oncolys 52 Homspera TM 52 topical anti infective 52 Mycamine 52 InterfeRx TM 52 DXL TM 52 OHR/AVR# 52 tigecycline 52 IMiDs R 52 Atugen 52 AstraZeneca Toprol XL 52 immunotherapeutic approaches 52 oral prodrug 52 MTP inhibitor 52 HuLuc# 52 ophthalmic diseases 52 Rezonic 52 Dexo 52 Helsinn 52 liposome formulations 52 NEUMUNE 52 Hemopurifier ® 52 herpetic keratitis 52 LentiVector technology 52 Relieva 52 Ipca Laboratories 52 pantoprazole 52 biogeneric drugs 52 Polyphenon ® E 52 antisense oligonucleotide 52 biosimilars 52 Suprax 52 quinolone 52 HCV polymerase inhibitors 52 reslizumab 52 Benazepril 52 rxRNA TM compounds 52 antagomirs 52 Nippon Shinyaku 52 CysDisplay 52 calcitonin 52 Bioral 52 LEUKINE 52 sodium glucose transporter 52 immunotoxins 52 biotherapeutics 52 udenafil 52 orally bioavailable 52 Vasotec 52 HuMax CD4 52 Anticalins ® 52 OvaRex ® MAb 52 HuCAL antibody 52 HSP# inhibitors 52 proprietary PEGylation 52 ADME properties 52 including eniluracil ADH 52 Zacharon 52 fusion inhibitor 52 ApoB SNALP 52 Tesmilifene 52 Sanochemia 52 Targeted Chemotherapy 52 immuno inflammatory diseases 52 small molecule 52 humanized monoclonal 52 adenosine A2A 52 Stapled Peptide 52 Lopinavir 52 MAbs 52 INT# [002] 52 PSN# [002] 52 Lipoxen 52 therapeutic peptide 52 Genfit 52 ProLindac 52 Azedra 52 Ramoplanin 52 Milnacipran 52 CDK inhibitors 52 Aurigene 52 Omacor ® 52 beta lactam 52 reformulates existing FDA 52 RTP #i 52 antigen sparing 52 RNAi therapeutic targeting PCSK9 52 DXL# 52 tubulin inhibitors 52 ACTCellerate 52 SNALP 52 Gabapentin 52 Ranbaxy 52 ASONEP TM 52 anti tubercular 52 Oracea TM 52 DP VPA 52 ANDAs 52 Protectans 52 FOLOTYN ® 52 Eraxis 52 targeted radiotherapeutic 52 otelixizumab 52 anti hypertensives 52 Spiegelmers 52 P#X# antagonist 52 RPL# 52 Pimavanserin 52 quinolone antibiotic 52 VersaFilm 52 peptide therapeutics 52 myelofibrosis polycythemia vera 52 Cefprozil 52 paromomycin 52 oral gallium 52 Invisicare 52 topical NSAID 52 Cyclosert TM 52 orally disintegrating 52 CB2 selective 52 iSONEP 52 MEK inhibitor 52 Heparins 52 Sumatriptan Succinate 52 Procognia 52 SYCREST 52 #ME# 52 VitiGam 52 Panzem R 52 polymorphs 52 anti thrombotics 52 anti infective treatments 52 Loramyc ® 52 Evolva 52 Intellikine 52 anticancer therapeutics 52 Drug Applications ANDAs 52 mucoadhesive 52 Traficet EN 52 Anticalin R 52 Thrombin 52 MAb 52 Orexo 52 amlodipine maleate 52 SoluBest 52 EpiCeram 52 PREOS R 52 Tarmogen 52 microtubule inhibitor 52 patent expiries 52 CD# antibody [001] 52 ITAX 52 Rheoscience 52 cephalosporins 52 Cerashield 52 OvaRex R 52 vitro ADME 52 NeoVisc 52 synthetic analogues 52 IMiDs ® 52 prescribed proton pump 52 Marqibo TM 52 donepezil hydrochloride 52 romazarit 52 Lisofylline LSF 52 siRNA sequences 52 THALOMID 52 Oasmia 52 cephalosporin antibiotics 52 Evoltra ® 52 JAK1 52 OMNARIS Nasal Spray 52 SinuNase TM 52 ANDA filings 52 immunotherapeutic agent 52 monoclonal antibody therapeutics 52 ProLindac TM 52 atacicept 52 Serdolect ® 52 monoclonal antibodies 52 Nanobodies R 52 Clavis Pharma 52 Amrubicin 52 molecular biology genomics 52 Daclizumab 52 antisense inhibitor 52 NASDAQ FLML 52 bio equivalence 52 Hycamtin 52 acyclovir Lauriad R 52 Fosphenytoin 52 immune modulatory 52 Solazed 52 DU #b 52 Cintredekin Besudotox 52 Vidaza R 52 CytoFab 52 acetylcholinesterase inhibitors 52 sodium thiosulfate STS 52 triphendiol 52 Quark Biotech 52 synthetic retinoid 52 LHRH antagonists 52 insulin analogs 52 monoclonal antibody therapies 52 InterfeRx 52 Prodarsan R 52 Lixivaptan 52 OXIGON TM 52 entacapone 52 therapeutic peptides 52 AstraZeneca Nexium 52 Impavido R 52 microRNA therapeutics 52 Alvesco ® 52 epothilones 51 dSLIM 51 Pronova 51 orally dosed 51 Eligard ® 51 Tranzyme 51 BioThrax Anthrax Vaccine Adsorbed 51 Vaccinex 51 Novartis Glivec 51 Zeatin 51 BAL# [002] 51 JBCPL 51 Combivir Kivexa 51 cytostatic 51 CoTherix 51 Dynepo 51 Torrent Pharmaceuticals 51 synergistic combinations 51 CTLA4 Ig 51 BRILINTA 51 Aurora kinase inhibitor 51 DiLA2 51 Shasun 51 Granulocyte Colony Stimulating Factor 51 VaxImmune 51 GRNVAC1 51 Ampligen ® 51 non nucleoside HCV 51 Zenpep 51 liposomal formulations 51 Regulus Therapeutics 51 luliconazole 51 ADME Tox 51 protein therapeutics 51 Neulasta R 51 2 inhibitor CYT# 51 Nicholas Piramal India 51 AstraZeneca AZN.L 行情 51 USFDA approval 51 punctal plugs 51 Tofacitinib 51 Tamsulosin 51 peptidomimetic 51 NexACT 51 IL# PE 51 Dalbavancin 51 molecularly targeted 51 Zolinza 51 danoprevir 51 SNALP technology 51 Enzo Therapeutics 51 biologics 51 Ticagrelor 51 acting muscarinic antagonist 51 KineMed 51 Argatroban 51 TIMERx 51 triterpenoids 51 Ustekinumab 51 FORMA Therapeutics 51 Cefprozil tablets 51 Cresp ® 51 Fumapharm 51 anticancer therapies 51 novel VDA molecule 51 Glatiramer Acetate 51 Pepducin 51 IBPL 51 dermatological diseases 51 Novartis NVS Snapshot Report 51 salmon calcitonin 51 Big Pharmas 51 ESBA# 51 bromfenac 51 Actimmune ® 51 Myocet 51 afamelanotide 51 BioSeek 51 Chemokine 51 betamethasone dipropionate 51 specific unsaturated lipids 51 TACLONEX 51 Intas Biopharmaceuticals 51 Humira adalimumab 51 POTELLIGENT R 51 ALN TTR# 51 immunoregulation 51 Campath ® 51 Loramyc ™ 51 Arcalyst 51 RESOLOR 51 transdermal gel 51 investigational therapies 51 myeloproliferative disorders 51 USL# 51 Lipofen 51 Gleevec Glivec 51 SGLT inhibitors 51 topical ocular 51 Spiegelmers R 51 topical antifungal 51 ImmunoCellular Therapeutics 51 synthetic siRNA 51 Ceftriaxone 51 Itero 51 Sublinox 51 Capsulution 51 Neurim Pharmaceuticals 51 AzaSite Plus 51 defensin mimetic antibiotic 51 enzyme inhibitor 51 neuronal nicotinic receptors NNRs 51 stem cell therapeutics 51 deforolimus 51 antibacterial compounds 51 Amlodipine Besylate Tablets 51 HCV protease inhibitor 51 Insugen 51 Quark Pharmaceuticals 51 Kyowa Kirin 51 immunotherapeutics 51 Efudex 51 Nanobodies TM 51 Gammagard Liquid 51 ViiV Healthcare 51 Hetero Drugs 51 Genentech Roche 51 novel RNAi therapeutics 51 Agenerase 51 SAR# [002] 51 autoimmune inflammatory 51 dorzolamide 51 dAb 51 oral salmon calcitonin 51 Glassia 51 Neovastat 51 BIOCEUTICALS 51 Sym# 51 Onco Therapies 51 antisense inhibitors 51 Biosimilar 51 BYETTA exenatide injection 51 HTS assay 51 ALN TTR 51 HIV protease inhibitors 51 Coartem ® 51 Femprox 51 Oxytrex 51 AN# novel 51 Fibroblast Growth Factor Receptor 51 Actemra tocilizumab 51 transmucosal delivery 51 Avidex 51 INOmax 51 Fournier Pharma 51 Cipla Ltd 51 active moiety 51 H2 antagonists 51 Enkephalin 51 angiogenesis inhibitor 51 YONDELIS R 51 vosaroxin 51 Torrent Pharma 51 Intravenous CP 51 Rapaflo 51 biotherapies 51 nonsedating antihistamine 51 SMARTICLES 51 VEGF Trap 51 activate SIRT1 51 Dr Reddy Laboratories 51 Idera Pharmaceuticals 51 OMP #M# 51 NeoVisc ® 51 epothilone 51 adenoviral 51 CCX# 51 NanoEmulsion 51 granisetron 51 lipid nanoparticle 51 Isis Pharma 51 HuCAL GOLD R 51 Solaraze 51 Lupin Pharmaceuticals 51 immunotoxin 51 2 methoxyestradiol 51 oncolytic virus 51 Fluticasone 51 Arimoclomol 51 Isogenica 51 optical biosensors 51 daptomycin 51 Uplyso 51 LAF# 51 Etravirine 51 motexafin gadolinium Injection 51 chemotherapeutics 51 SOLODYN 51 monoclonals 51 Fc fusion protein 51 Liposomal 51 UCB Cimzia 51 Crofelemer 51 PPAR gamma agonists 51 targeting CD# 51 DYNEPO 51 HepaGam B R 51 MNC pharma 51 bulk actives 51 Abiraterone acetate 51 proprietary LNA 51 anti infectives 51 Angiocept 51 IFNs 51 COREG CR 51 ciclesonide 51 HepDirect technology 51 Taxol ® 51 PROVIGIL 51 Allovectin 7 51 delta isoform 51 belinostat 51 Zirgan 51 Fenofibrate 51 Monoclonal antibody 51 KSP inhibitor 51 Biotica 51 GA GCB 51 bexarotene 51 DMFs 51 MVA BN R 51 Retavase 51 Prilosec omeprazole 51 Aganocide TM 51 tolevamer 51 delipidation 51 Zydus 51 generic biologic 51 Biocon Limited 51 indibulin 51 Tarvacin TM 51 Morphosys 51 Multiferon ® 51 Atorvastatin 51 deuterium containing 51 Copaxone glatiramer acetate 51 Dyax phage display 51 liposomal 51 PARP inhibitor 51 transfection reagents 51 Darapladib 51 TAFA# 51 Solazed TM 51 histone deacetylase inhibitors 51 recombinant biopharmaceutical 51 clinically validated targets 51 WHO prequalification 51 Guanilib 51 Ridaforolimus 51 GIPET r 51 ATL# [001] 51 Anticalin 51 Tiazac 51 beta 1a 51 NASDAQ BTRX pharmaceutical 51 VALSTAR 51 novel peptide therapeutics 51 Aceon 51 Remicade infliximab 51 polymerase inhibitor 51 rhThrombin 51 SYN X 51 Alocrest 51 HDAC inhibition 51 URG# 51 rThrombin 51 antihypertension 51 Ibis Biosciences 51 immuno modulatory 51 ofloxacin 51 phage display technology 51 plasma fractionation 51 NOXXON 51 Glenmark Pharma 51 orphan GPCRs 51 levocetirizine 51 eflornithine 51 Zometa zoledronic acid 51 acne impetigo 51 Tazorac 51 acetonide FA 51 selective inhibition 51 JUVISTA 51 Dabur Pharma 51 OMAPRO 51 ESBATech 51 Lycera 50 pyrimidines 50 TLR Therapeutics 50 Active Pharmaceutical Ingredients 50 p# inhibitors 50 highly selective endothelin 50 Streptomyces bacteria 50 Viatris 50 vivo fluorescence imaging 50 Tß4 50 BioMarck 50 Grandix 50 Relistor 50 CBLC# 50 soft gelatin capsule 50 CXCR4 receptor 50 glucokinase activator 50 deacetylase inhibitors 50 cefdinir 50 Sporanox 50 Elan Pharma 50 POTELLIGENT R Technology 50 ALD# 50 Tarvacin 50 Domantis 50 CRAMS 50 Numax 50 systemic antifungal 50 Addrenex 50 PHX# 50 HSP# inhibitor 50 small molecule inhibitors 50 ActivX 50 peptide antigens 50 pancreatic enzyme replacement 50 Isis antisense 50 vitro assay 50 carbohydrate polymers 50 Urocidin TM 50 Quark Biotech Inc. 50 cephalosporin 50 Tekturna HCT 50 Gatifloxacin 50 RNAi compounds

Back to home page